. . . . . . . . . . . . . . . . . . . "cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) -> bp(GO:\"cell migration\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Second, such activation appears to be the result of affinity modulation because VEGF165-stimulated cells acquired the capacity to bind the soluble monovalent ligand- mimetic anti-aVb3 antibody, WOW-1 Fab. Fourth, a particularly relevant functional consequence of VEGF165 activation of aVb3 is the augmentation of cell migration." . . "Selventa" . . . . "2014-07-03T14:29:53.282+02:00"^^ . . .